Tags » Chronic Lymphocytic Leukemia

My Journey

I would like to tell you a story I have read many times. It is an old story, written very long ago, a story that everyone should know. 947 more words


FDA Breakthrough Therapy Designation: 5th Approval Is For Gilead Sciences

The FDA announces on July 23rd, that Gilead Sciences’ drug, Zydelig (Idelalisib), receives 3 approvals for blood cancers.

The 1st FDA approval is the “traditional approval” of Gilead Sciences’ FDA Breakthrough Therapy (BTD) Designated product, Zydelig, for relapsed Chronic Lymphocytic Leukemia (CLL). 310 more words

Orphan Drug Development

Zydelig Approved by FDA for Patients with CLL, FL, & SLL

Earlier this afternoon the FDA announced the approval of Zydelig (idelalisib) for patients with relapsed chronic lymphocytic leukemia (CLL). Accelerated approval was also granted for the use of  Zydelig in patients with relapsed follicular B-cell non-Hodgkin lymphoma (FL) and relapsed small lymphocytic lymphoma (SLL). 239 more words

Lymphoma News

Day – 6 and Counting

I’m glad today is over. We started out being early for everything, blood/specimen collection and a CT of the sinuses (just regular sinusitis as it turned out) then things kind of went to pot, timing wise. 463 more words


Day-9: Hurry up and Wait

All the travel is done. All the tests are complete. The first round of chemotherapy has been infused. That was the “hurry up.” Now comes the wait. 533 more words


D-15: Life’s a Whirlwind

Whew! Life since last Tuesday has been a whirlwind of activity or trying to catch enough energy to enter the fray again. I have had time to write; I haven’t had the energy. 554 more words


T-17: Goin' back to Houston, Houston, Houston

Dean Martin had it at least partially correct; we’re goin’ back to Houston, but not because it is gettin’ lonely in this old town. We will leave all of our friends behind and go to the big city because that is where the healin’ is. 506 more words

MD Anderson